The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for Helicobacter pylori Eradication: A Randomized, Double-Blind Clinical Trial

Table 2

The eradication rates of the BPAL-7 and BPAL-10 regimens.

Analyses	BPAL-7 regimen (n = 107)	BPAL-10 regimen (n = 109)	value
Intention-to-treat	54 (49.1)	69 (62.7)	0.037
Per-protocol	51 (47.6)	68 (62.4)	0.024

Values were demonstrated as numbers (percentages). ¹⁴C-urea breath test was conducted to confirm the eradication of H. pylori two months after the end of treatment. A Chi-square test was performed to compare variables between groups. BPAL-7 and BPAL-10: bismuth-based quadruple therapies containing pantoprazole, amoxicillin, and levofloxacin for seven and ten days, respectively.